|

Oxaliplatin + 5-Fluorouracil/Leucovorin Clinical Trials

2 actively recruiting trials

▲ +1 trial since August 2026

Pipeline

Phase 2: 1Phase 4: 1

Top Sponsors

  • Zhai Wenlong1
  • First Affiliated Hospital of Zhejiang University1

Indications

  • Cancer2
  • Malignant Biliary Tract Tumors1
  • Cholangiocarcinoma1
  • Biliary Tract Cancer1
  • Bile Duct Carcinoma1

Other2 trials

A Prospective, Open-Label, Randomized Controlled Clinical Study Comparing Hepatic Arterial Infusion Chemotherapy (HAIC) With Capecitabine as Adjuvant Therapy After Radical Surgery for Malignant Biliary Tract Tumors
Phase 4
Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.